CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 425 of 984 entries

View as:

An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT05976334 Org: User:

Start: 11/14/23 End: 07/16/24 Due: 07/16/25

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01829464 Org: User:

Start: 05/31/13 End: 03/31/14 Due: 03/31/15

Efficacy and Safety of Ramelteon on Chronic Insomnia

Phase: N/A Priority: Normal

NCT ID: NCT00915135 Org: User:

Start: 05/31/02 End: 12/31/03 Due: 12/31/04

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT01390545 Org: User:

Start: 08/31/11 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

Phase: N/A Priority: Normal

NCT ID: NCT02128490 Org: User:

Start: 05/31/14 End: 10/31/15 Due: 10/31/16

Safety and Efficacy of Ramelteon in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00671190 Org: User:

Start: 03/31/05 End: 05/31/05 Due: 05/31/06

Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia

Phase: N/A Priority: Normal

NCT ID: NCT00656994 Org: User:

Start: 01/31/03 End: 07/31/04 Due: 07/31/05

Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease

Phase: N/A Priority: Normal

NCT ID: NCT03035058 Org: User:

Start: 02/28/17 End: 01/31/21 Due: 01/31/22

Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT02098733 Org: User:

Start: 06/30/11 End: 05/31/14 Due: 05/31/15

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02113020 Org: User:

Start: 02/28/14 End: 09/30/14 Due: 09/30/15

A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01542632 Org: User:

Start: 02/01/12 End: 01/10/14 Due: 01/10/15

A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT05064449 Org: User:

Start: 10/14/21 End: 11/30/21 Due: 11/30/22

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Phase: N/A Priority: Normal

NCT ID: NCT04557189 Org: User:

Start: 10/20/20 End: 03/21/22 Due: 03/21/23

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT01289132 Org: User:

Start: 07/31/07 End: 07/31/08 Due: 07/31/09

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal

NCT ID: NCT01263509 Org: User:

Start: 06/30/07 End: 10/31/08 Due: 10/31/09

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants

Phase: N/A Priority: Normal

NCT ID: NCT02389881 Org: User:

Start: 02/28/15 End: 12/31/15 Due: 12/31/16

Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935

Phase: N/A Priority: Normal

NCT ID: NCT02201056 Org: User:

Start: 07/31/14 End: 07/31/15 Due: 07/31/16

A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal

NCT ID: NCT05886491 Org: User:

Start: 07/11/23 End: 06/30/27 Due: 06/30/28

Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout

Phase: N/A Priority: Normal

NCT ID: NCT01078389 Org: User:

Start: 03/31/10 End: 09/30/13 Due: 09/30/14

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

Phase: N/A Priority: Normal

NCT ID: NCT01452685 Org: User:

Start: 03/31/12 End: 12/31/13 Due: 12/31/14

Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms

Phase: N/A Priority: Normal

NCT ID: NCT01990339 Org: User:

Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT02039505 Org: User:

Start: 02/04/14 End: 06/28/18 Due: 06/28/19

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Phase: N/A Priority: Normal

NCT ID: NCT01686711 Org: User:

Start: 09/30/12 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Phase: N/A Priority: Normal

NCT ID: NCT02400775 Org: User:

Start: 03/31/15 End: 04/30/16 Due: 04/30/17

Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT01564862 Org: User:

Start: 04/30/12 End: 02/28/14 Due: 02/28/15

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors	NCT05976334	Takeda	user2@example.com	None	2023-11-14	2024-07-16	2025-07-16	-	-	2025-07-14
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes	NCT01829464	Takeda	user2@example.com	None	2013-05-31	2014-03-31	2015-03-31	-	-	2025-07-14
Efficacy and Safety of Ramelteon on Chronic Insomnia	NCT00915135	Takeda	user2@example.com	None	2002-05-31	2003-12-31	2004-12-31	-	-	2025-07-14
VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis	NCT01390545	Takeda	user2@example.com	None	2011-08-31	2012-10-31	2013-10-31	-	-	2025-07-14
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment	NCT02128490	Takeda	user2@example.com	None	2014-05-31	2015-10-31	2016-10-31	-	-	2025-07-14
Safety and Efficacy of Ramelteon in Healthy Subjects	NCT00671190	Takeda	user2@example.com	None	2005-03-31	2005-05-31	2006-05-31	-	-	2025-07-14
Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia	NCT00656994	Takeda	user2@example.com	None	2003-01-31	2004-07-31	2005-07-31	-	-	2025-07-14
Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease	NCT03035058	Takeda	user2@example.com	None	2017-02-28	2021-01-31	2022-01-31	-	-	2025-07-14
Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus	NCT02098733	Takeda	user2@example.com	None	2011-06-30	2014-05-31	2015-05-31	-	-	2025-07-14
A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects	NCT02113020	Takeda	user2@example.com	None	2014-02-28	2014-09-30	2015-09-30	-	-	2025-07-14
A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers	NCT01542632	Takeda	user2@example.com	None	2012-02-01	2014-01-10	2015-01-10	-	-	2025-07-14
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults	NCT05064449	Takeda	user2@example.com	None	2021-10-14	2021-11-30	2022-11-30	-	-	2025-07-14
A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery	NCT04557189	Takeda	user2@example.com	None	2020-10-20	2022-03-21	2023-03-21	-	-	2025-07-14
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension	NCT01289132	Takeda	user2@example.com	None	2007-07-31	2008-07-31	2009-07-31	-	-	2025-07-14
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan	NCT01263509	Takeda	user2@example.com	None	2007-06-30	2008-10-31	2009-10-31	-	-	2025-07-14
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants	NCT02389881	Takeda	user2@example.com	None	2015-02-28	2015-12-31	2016-12-31	-	-	2025-07-14
Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935	NCT02201056	Takeda	user2@example.com	None	2014-07-31	2015-07-31	2016-07-31	-	-	2025-07-14
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia	NCT05886491	Takeda	user2@example.com	None	2023-07-11	2027-06-30	2028-06-30	-	-	2025-07-14
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout	NCT01078389	Takeda	user2@example.com	None	2010-03-31	2013-09-30	2014-09-30	-	-	2025-07-14
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis	NCT01452685	Takeda	user2@example.com	None	2012-03-31	2013-12-31	2014-12-31	-	-	2025-07-14
Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms	NCT01990339	Takeda	user2@example.com	None	2008-12-31	2010-12-31	2011-12-31	-	-	2025-07-14
Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis	NCT02039505	Takeda	user2@example.com	None	2014-02-04	2018-06-28	2019-06-28	-	-	2025-07-14
A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322	NCT01686711	Takeda	user2@example.com	None	2012-09-30	2013-12-31	2014-12-31	-	-	2025-07-14
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.	NCT02400775	Takeda	user2@example.com	None	2015-03-31	2016-04-30	2017-04-30	-	-	2025-07-14
Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder	NCT01564862	Takeda	user2@example.com	None	2012-04-30	2014-02-28	2015-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance